Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
Recruiting now · Phase 2 · Has a placebo group
Conditions studied: Recurrent Acute Pancreatitis
In brief
This clinical will evaluate the safety, tolerability and early efficacy of pirenidone in patients with recurrent acute pancreatitis.
Key facts
- Study ID
- NCT06253117
- Run by
- University of Alabama at Birmingham
- People needed
- 60
- Starts
- 2024-06-27
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)
- University of Iowa Health Care — Iowa City, Iowa, United States (enrolling)
- Mayo Clinic — Rochester, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.